Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

YS Biopharma Co., Ltd. - Ordinary Shares (NQ: YS )

0.7700 -0.0300 (-3.75%)
Streaming Delayed Price Updated: 1:37 PM EDT, Apr 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 20,168
Open 0.7700
Bid (Size) 0.7700 (2)
Ask (Size) 0.8200 (2)
Prev. Close 0.8000
Today's Range 0.7700 - 0.8500
52wk Range 0.3503 - 1.970
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
YS Stock Earnings: YS Biopharma Co Misses EPS, Beats Revenue for Q3 2024
YS stock results show that YS Biopharma Co missed analyst estimates for earnings per share but beat on revenue for the third quarter of 2024. 
Via InvestorPlace
Chinese Biotech YS Biopharma's Next-Gen Rabies Vaccine Non-Inferior To Approved Competitor
YS Biopharma unveils interim results from Phase 3 trial of PIKA Rabies Vaccine, meeting primary endpoints. With accelerated immunity in 7 days, it could revolutionize rabies prevention. 
Via Benzinga

Performance

YTD
+50.92%
+50.92%
1 Month
+22.22%
+22.22%
3 Month
+75.00%
+75.00%
6 Month
+88.86%
+88.86%
1 Year
-50.96%
-50.96%

More News

Read More
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Shareholders of YS Biopharma Announce an Extraordinary General Meeting
Via GlobePRwire
YS Stock Earnings: YS Biopharma Co Misses EPS, Misses Revenue for Q2 2024
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
3 Penny Stocks That Are Too Compelling to Ignore
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why NIO Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Alpha Tau Medical Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why NovoCure Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why LQR House Shares Are Trading Higher By Around 41%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Nasdaq Gains Over 100 Points; YS Biopharma Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures US Equities
Why Nordstrom Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why YS Biopharma Stock Is Rocketing Higher
Via Benzinga
Nasdaq Edges Lower; Domo Shares Plummet
Via Benzinga
Topics Stocks
Exposures US Equities
Dow Jumps Over 200 Points; Hibbett Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.